MLchartDataset catalogue

Allogeneic melanoma vaccine AGI-101H

Term · Oncology and biomedicine · MLC-T-ONC-009918

A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-009918
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009918",
  "term": "Allogeneic melanoma vaccine AGI-101H",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/allogeneic-melanoma-vaccine-agi-101h/"
}

Record 804 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.